[Failure mode and effects analysis on computerized drug prescriptions]

J A Paredes-Atenciano1, J P Roldán-Aviña2, Mercedes González-García3

  • 1Departamento de Hospitalización, Hospital de Alta Resolución de Écija (Agencia Sanitaria Bajo Guadalquivir), Écija, Sevilla, España.

Abstract

Insights

Failure Mode and Effects Analysis (FMEA) identified and reduced drug prescription errors by 22.2% in a hospital setting. Key areas for improvement included unspecified administration routes and dosages, enhancing patient safety.

Area of Science:

  • Medical Informatics
  • Patient Safety
  • Clinical Pharmacy

Background:

  • Drug prescription errors pose a significant risk to patient safety.
  • Accurate and complete prescriptions are crucial for effective treatment.

Purpose of the Study:

  • To identify and analyze drug prescription errors using Failure Mode and Effects Analysis (FMEA).
  • To evaluate the effectiveness of FMEA in improving prescription accuracy and patient safety.

Main Methods:

  • A multidisciplinary team applied FMEA to analyze free-text drug prescriptions.
  • A cross-sectional observational study with a two-phase audit (pre- and post-intervention) was conducted.
  • Sample size included 679 medical records from 2,096 patients.

Main Results:

  • Overall prescription errors decreased by 22.2% after the intervention.
  • FMEA highlighted high-risk areas such as unspecified route of administration and dosage.
  • Specific errors like incorrect dosing time and contraindications were identified and addressed.

Conclusions:

  • FMEA is an effective tool for identifying and analyzing drug prescription errors.
  • Implementing FMEA improved the clinical safety of drug prescriptions.
  • Mandatory completion of all prescription fields is recommended to prevent errors.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
97
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
103
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
287
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
192
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K